BioAtla, Inc. (BCAB) — Financial statements
Income statement, balance sheet, and cash flow for BioAtla, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 2↓81.8% | 11 | 0.00 | 0.00↓100.0% | 0.25 | |
| Cost of Revenue | 0.00↓100.0% | 0.93↓24.2% | 1↑1.8% | 1 | 0.00 | |
| Gross Profit | 2↓80.1% | 10↑925.1% | -1↓1.8% | -1↓579.6% | 0.25 | |
| Operating Expenses | ||||||
| R&D Expenses | 44↓30.9% | 63↓39.2% | 104↑30.7% | 79↑36.2% | 58 | |
| General & Administrative Expenses | 18↓18.8% | 22↓15.8% | 26↓9.9% | 29↓25.0% | 38 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 18↓18.8% | 22↓15.8% | 26↓9.9% | 29↓25.0% | 38 | |
| Other Expenses | 0.00↑100.0% | -0.93↑24.2% | -1↓1.8% | -1 | 0.00 | |
| Operating Expenses | 61↓27.0% | 84↓34.6% | 128↑20.1% | 107↑10.6% | 97 | |
| Total Costs & Expenses | 61↓27.8% | 85↓34.5% | 130↑19.9% | 108↑11.8% | 97 | |
| Operating Results | ||||||
| Operating Income | -59↑19.8% | -74↑43.0% | -130↓19.9% | -108↓12.1% | -96 | |
| Depreciation & Amortization | 0.37↓59.7% | 0.93↓24.2% | 1↑1.8% | 1↓9.8% | 1 | |
| EBITDA | -59↑19.3% | -73↑40.3% | -122↓16.1% | -105↓11.9% | -94 | |
| EBIT | -59↑19.8% | -74↑40.1% | -123↓15.9% | -106↓11.6% | -95 | |
| Interest & Other Income | ||||||
| Net Interest Income | 0.84↓75.0% | 3↓46.6% | 6↑283.0% | 2↑374.9% | 0.35 | |
| Interest Income | 0.84↓75.0% | 3↓46.6% | 6↑283.0% | 2↑370.9% | 0.35 | |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00↓100.0% | 0.00 | |
| Non-Operating Income | 0.00 | 0.00↑100.0% | -6↓275.5% | -2↓59.3% | -1 | |
| Other Income / Expenses | -0.30↓107.2% | 4↓33.1% | 6↑275.5% | 2↑59.7% | 1 | |
| Income Before Tax | -60↑14.6% | -70↑43.5% | -123↓15.9% | -106↓11.6% | -95 | |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -60↑14.6% | -70↑43.5% | -123↓15.9% | -106↓11.6% | -95 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -60↑14.6% | -70↑43.5% | -123↓17.3% | -105↓10.4% | -95 | |
| Bottom-Line Net Income | -60↑14.6% | -70↑43.5% | -123↓15.9% | -106↓11.6% | -95 | |
| EPS (Basic) | -50.50↑29.9% | -72.00↑44.2% | -129.00↑5.8% | -137.00↑0.7% | -138.00 | |
| EPS (Diluted) | -50.50↑29.9% | -72.00↑44.2% | -129.00↑5.8% | -137.00↑0.7% | -138.00 | |
| Weighted Average Shares | 1↑21.1% | 0.97↑1.7% | 0.96↑22.7% | 0.78↑12.6% | 0.69 | |
| Weighted Average Diluted Shares | 1↑21.1% | 0.97↑1.7% | 0.96↑22.7% | 0.78↑12.6% | 0.69 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.